Publication | Closed Access

A Phase II Study: Efficacy of the Gene Therapy of the MVA E2 Recombinant Virus in the Treatment of Precancerous Lesions (NIC I and NIC II) Associated with Infection of Oncogenic Human Papillomavirus

Human Papillomavirus VaccinesMedicinePathologyVirologyPhase Ii StudyNic IiGene VectorAdult T-cell Leukemia-lymphomaOncologyViral OncologyPrecancerous LesionsCancer-associated Virus